Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

AP-4ε Inhibitors

The class of chemicals known as AP-4ε Inhibitors includes compounds that influence cellular processes and signaling pathways associated with the function of the AP-4 complex, of which AP-4ε is a part. These chemicals exert their effects through various mechanisms that can impact the intracellular trafficking and vesicular transport operations in which AP-4ε plays a crucial role. The AP-4 complex is involved in the sorting of proteins to endosomes and lysosomes, and any disruption in the pathways that regulate these processes can affect the function of AP-4ε.

The chemicals listed in the table affect various aspects of cellular function, including Golgi apparatus dynamics, microtubule stability, actin cytoskeleton integrity, vesicle scission, motor protein activity, Rho GTPase signaling, phosphoinositide metabolism, and kinase activity. Each of these aspects plays a role in vesicular trafficking and membrane organization, processes that are fundamental to the proper functioning of AP-4ε. By altering the structure and function of the Golgi, brefeldin A and monensin can affect the formation and transport of vesicles, which are key steps in AP-4ε-mediated trafficking. The integrity and dynamics of the cytoskeleton are essential for vesicular movement, and chemicals like nocodazole, paclitaxel, cytochalasin D, latrunculin A, and blebbistatin can influence these factors, thereby potentially impacting AP-4ε function. Dynasore's inhibition of dynamin can affect endocytic trafficking, while ML-141's inhibition of Cdc42 can affect cytoskeletal organization and vesicular trafficking. Wortmannin's inhibition of PI3K can alter signaling pathways critical for membrane trafficking.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts Golgi structure and function, which can affect AP-4ε-mediated trafficking by altering vesicle formation and transport.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Ionophore that disrupts Golgi function, potentially affecting AP-4ε-dependent vesicular trafficking by altering ion gradients and pH.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Destabilizes microtubules, which can disrupt cytoskeletal dynamics and vesicle transport processes involving AP-4ε.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Stabilizes microtubules and can indirectly affect AP-4ε function by altering microtubule dynamics and vesicle trafficking.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Inhibits dynamin, which can indirectly affect AP-4ε-dependent endocytic trafficking by blocking vesicle scission from the membrane.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Disrupts actin filaments, potentially affecting AP-4ε-mediated trafficking by altering cytoskeletal organization and vesicle movement.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Binds to actin monomers and inhibits polymerization, which can impact AP-4ε-dependent trafficking by disrupting actin cytoskeleton dynamics.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$72.00
$265.00
$495.00
$968.00
(2)

Inhibits myosin II, potentially affecting AP-4ε function in vesicle transport by altering motor protein-driven vesicle motility.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K, potentially affecting AP-4ε function by altering phosphoinositide signaling involved in membrane trafficking.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

Blocks clathrin-mediated endocytosis, which can indirectly affect AP-4ε function by altering the endocytic pathway and vesicle formation.